ImmuCell Stock (NASDAQ: ICCC) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 10.88K |
Day Range | - - - |
52 Wk Range | 4.05 - 5.87 |
Market Cap | $33.58M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 0.09% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ImmuCell (NASDAQ:ICCC) through any online brokerage.
Other companies in ImmuCell’s space includes: NKGen Biotech (NASDAQ:NKGN), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX), Bolt Biotherapeutics (NASDAQ:BOLT) and Palatin Techs (AMEX:PTN).
There is no analysis for ImmuCell.
There is no analysis for ImmuCell to provide a consensus price target.
The stock price for ImmuCell (NASDAQ: ICCC) is $4.2989 last updated July 18, 2024 at 9:06 AM EDT.
There are no upcoming dividends for ImmuCell.
ImmuCell’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for ImmuCell.
ImmuCell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.